New Technologies for Outcome Measures in Retinal Disease: Review from the European Vision Institute Special Interest Focus Group.

Academies and Institutes Europe Focus Groups Humans Outcome Assessment, Health Care Retina / diagnostic imaging Retinal Diseases / diagnosis Tomography, Optical Coherence / methods
Artificial intelligence Diagnostics Machine learning Retina Retinal disease Technologies

Journal

Ophthalmic research
ISSN: 1423-0259
Titre abrégé: Ophthalmic Res
Pays: Switzerland
ID NLM: 0267442

Informations de publication

Date de publication:
2020
Historique:
received: 21 05 2019
accepted: 03 07 2019
pubmed: 29 7 2019
medline: 8 1 2021
entrez: 29 7 2019
Statut: ppublish

Résumé

Novel diagnostic tools to measure retinal function and structure are rapidly being developed and introduced into clinical use. Opportunities exist to use these informative and robust measures as endpoints for clinical trials to determine efficacy and to monitor safety of therapeutic interventions. In order to inform researchers and clinician-scientists about these new diagnostic tools, a workshop was organized by the European Vision Institute. Invited speakers highlighted the recent advances in state-of-the-art technologies for outcome measures in the field of retina. This review highlights the workshop's presentations in the context of published literature.

Identifiants

DOI: 10.1159/000501887 PMID: 31352462
pubmed: 31352462
pii: 000501887
doi: 10.1159/000501887
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

77-87

Informations de copyright

© 2019 S. Karger AG, Basel.

Auteurs

Maria Della Volpe-Waizel (M)

Department of Ophthalmology, University of Basel, Basel, Switzerland.
Institute of Molecular and Clinical Ophthalmology (IOB), Basel, Switzerland.

Ghislaine L Traber (GL)

Department of Ophthalmology, University of Basel, Basel, Switzerland.
Institute of Molecular and Clinical Ophthalmology (IOB), Basel, Switzerland.

Peter Maloca (P)

Institute of Molecular and Clinical Ophthalmology (IOB), Basel, Switzerland.

Martin Zinkernagel (M)

Department of Ophthalmology and Department of Clinical Research, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

Ursula Schmidt-Erfurth (U)

Medical University of Vienna, Department of Ophthalmology, Vienna, Austria.

Gary Rubin (G)

UCL University College London, Institute of Ophthalmology, London, United Kingdom.

Botond Roska (B)

Institute of Molecular and Clinical Ophthalmology (IOB), Basel, Switzerland.

Tilman Otto (T)

Heidelberg Engineering GmbH, Heidelberg, Germany.

Richard G Weleber (RG)

Casey Eye Institute, Departments of Ophthalmology and Molecular and Medical Genetics, University of Oregon Health and Science University, Portland, Oregon, USA.

Hendrik P N Scholl (HPN)

Department of Ophthalmology, University of Basel, Basel, Switzerland, Hendrik.Scholl@usb.ch.
Institute of Molecular and Clinical Ophthalmology (IOB), Basel, Switzerland, Hendrik.Scholl@usb.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Organisations et économie des soins de santé › Organismes › Académies et instituts › New Technologies for Outcome Measures in...
questionsmedicales.fr › Régions géographiques › Europe › New Technologies for Outcome Measures in...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Collecte de données › Groupes de discussion › New Technologies for Outcome Measures in...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › New Technologies for Outcome Measures in...
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Qualité des soins de santé › Mécanismes d'évaluation des soins de santé › Évaluation des résultats et des processus en soins de santé › Évaluation de résultat (soins) › New Technologies for Outcome Measures in...
questionsmedicales.fr › Organes des sens › Oeil › Rétine › New Technologies for Outcome Measures in...
questionsmedicales.fr › Maladies de l'oeil › Rétinopathies › New Technologies for Outcome Measures in...
questionsmedicales.fr › Techniques d'investigation › Imagerie optique › Tomographie optique › Tomographie par cohérence optique › New Technologies for Outcome Measures in...